Cargando…
Intravesical gemcitabine for non-muscle invasive bladder cancer: An abridged Cochrane Review
PURPOSE: To assess the comparative effectiveness and toxicity of intravesical gemcitabine instillation for non-muscle invasive bladder cancer (NMIBC). MATERIALS AND METHODS: We performed a comprehensive literature search on 11 September 2020. We included RCTs in which participants received intravesi...
Autores principales: | Han, Mi Ah, Maisch, Philipp, Jung, Jae Hung, Hwang, Jun Eul, Narayan, Vikram, Cleves, Anne, Hwang, Eu Chang, Dahm, Philipp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Urological Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566788/ https://www.ncbi.nlm.nih.gov/pubmed/34729962 http://dx.doi.org/10.4111/icu.20210265 |
Ejemplares similares
-
Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: Abridged summary of the Cochrane Review
por: Schmidt, Stefanie, et al.
Publicado: (2020) -
A systematic assessment of Cochrane reviews and systematic reviews published in high-impact medical journals related to cancer
por: Goldkuhle, Marius, et al.
Publicado: (2018) -
Sequential Intravesical Gemcitabine and Docetaxel for the Salvage Treatment of Non-Muscle Invasive Bladder Cancer
por: Steinberg, Ryan L., et al.
Publicado: (2015) -
Intravesical Gemcitabine versus Intravesical Bacillus Calmette–Guérin for the Treatment of Non-Muscle Invasive Bladder Cancer: An Evaluation of Efficacy and Toxicity
por: Prasanna, Thiru, et al.
Publicado: (2017) -
Oncological Outcomes of Sequential Intravesical Gemcitabine and Docetaxel in Patients with Non-Muscle Invasive Bladder Cancer
por: Milbar, Niv, et al.
Publicado: (2017)